UGT1A1 polymorphism has a prognostic effect in patients with stage IB or II uterine cervical cancer and one or no metastatic pelvic nodes receiving irinotecan chemotherapy: a retrospective study

Peer Review reports

Original Submission
6 May 2020	Submitted	Original manuscript
20 May 2020	Reviewed	Reviewer Report
11 Jun 2020	Reviewed	Reviewer Report
1 Jul 2020	Author responded	Author comments - Hideki Matsuoka
Resubmission - Version 2
1 Jul 2020	Submitted	Manuscript version 2
13 Jul 2020	Reviewed	Reviewer Report
13 Jul 2020	Reviewed	Reviewer Report
20 Jul 2020	Author responded	Author comments - Hideki Matsuoka
Resubmission - Version 3
20 Jul 2020	Submitted	Manuscript version 3
Publishing
27 Jul 2020	Editorially accepted
5 Aug 2020	Article published	10.1186/s12885-020-07225-1

Back to article page